Standing Issue Threatens 15 Zometa Suits In NJ

Law360, New York (December 02, 2013, 2:30 PM ET) -- A New Jersey judge has dismissed 15 lawsuits over Novartis Pharmaceuticals Corp.’s bone-strengthening drug Zometa, based on a failure to file certain documents intended to show that the cases belonged in the multicounty litigation.

Judge Jessica Mayer said in an order issued Nov. 19 that plaintiffs’ counsel were required to file affidavits or certifications with Middlesex County Superior Court to indicate that each case had a real party in interest with standing, which the 15 named cases had failed to do.

The judge dismissed the cases...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required